Analyzing the human pancreas to understand Type 2 Diabetes
Human Pancreas Analysis Program for Type 2 Diabetes (HPAP-T2D)
This study is looking at human pancreas samples to learn more about Type 2 Diabetes, and it's for anyone interested in how this condition affects the body, as researchers hope to gather important information that could lead to better treatments.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pennsylvania NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project ID | NIH-11043742 on NIH RePORTER |
What this research studies
This research program focuses on the comprehensive analysis of human pancreases to better understand Type 2 Diabetes. It involves the procurement of human pancreas samples, isolation of islets, and detailed physiological and molecular profiling of these tissues. Advanced technologies will be used to analyze the islets and other pancreatic tissues, including genetic and cellular assessments. The goal is to create a rich database that integrates clinical data with biological insights to enhance our understanding of diabetes.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with Type 2 Diabetes, particularly those who are willing to contribute biological samples.
Not a fit: Patients who do not have Type 2 Diabetes or those who are not willing to participate in sample donation may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatments and management strategies for patients with Type 2 Diabetes.
How similar studies have performed: Previous research has shown success in similar approaches that analyze pancreatic tissues to gain insights into diabetes, making this a promising continuation of established methodologies.
Where this research is happening
Philadelphia, United States
- University of Pennsylvania — Philadelphia, United States (Active)
Researchers
- Principal investigator: Kaestner, Klaus H — University of Pennsylvania
- Study coordinator: Kaestner, Klaus H
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.